Repare Therapeutics Statistics
Total Valuation
RPTX has a market cap or net worth of $126.35 million. The enterprise value is -$56.14 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RPTX has 42.51 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 42.51M |
| Shares Outstanding | 42.51M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 33.17% |
| Float | 20.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.81 |
| Forward PS | 9.25 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.45, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.45 |
| Quick Ratio | 6.23 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.17% and return on invested capital (ROIC) is -27.79%.
| Return on Equity (ROE) | -41.17% |
| Return on Assets (ROA) | -23.39% |
| Return on Capital (ROIC) | -27.79% |
| Revenue Per Employee | $371,642 |
| Profits Per Employee | -$469,542 |
| Employee Count | 179 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RPTX has paid $1.63 million in taxes.
| Income Tax | 1.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.43% in the last 52 weeks. The beta is 0.71, so RPTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -43.43% |
| 50-Day Moving Average | 3.41 |
| 200-Day Moving Average | 3.91 |
| Relative Strength Index (RSI) | 34.65 |
| Average Volume (20 Days) | 112,990 |
Short Selling Information
The latest short interest is 749,735, so 1.76% of the outstanding shares have been sold short.
| Short Interest | 749,735 |
| Short Previous Month | 717,028 |
| Short % of Shares Out | 1.76% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 6.38 |
Income Statement
In the last 12 months, RPTX had revenue of $66.52 million and -$84.05 million in losses. Loss per share was -$1.99.
| Revenue | 66.52M |
| Gross Profit | -57.80M |
| Operating Income | -92.22M |
| Pretax Income | -83.68M |
| Net Income | -84.05M |
| EBITDA | -90.24M |
| EBIT | -92.22M |
| Loss Per Share | -$1.99 |
Full Income StatementBalance Sheet
The company has $179.43 million in cash and $2.56 million in debt, giving a net cash position of $176.87 million or $4.16 per share.
| Cash & Cash Equivalents | 179.43M |
| Total Debt | 2.56M |
| Net Cash | 176.87M |
| Net Cash Per Share | $4.16 |
| Equity (Book Value) | 174.96M |
| Book Value Per Share | 4.12 |
| Working Capital | 169.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$77.28 million and capital expenditures -$398,000, giving a free cash flow of -$77.68 million.
| Operating Cash Flow | -77.28M |
| Capital Expenditures | -398,000 |
| Free Cash Flow | -77.68M |
| FCF Per Share | -$1.83 |
Full Cash Flow StatementMargins
Gross margin is -86.88%, with operating and profit margins of -138.62% and -126.34%.
| Gross Margin | -86.88% |
| Operating Margin | -138.62% |
| Pretax Margin | -123.89% |
| Profit Margin | -126.34% |
| EBITDA Margin | -135.65% |
| EBIT Margin | -138.62% |
| FCF Margin | -116.49% |
Dividends & Yields
RPTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | -69.62% |
| FCF Yield | -64.34% |
Analyst Forecast
The average price target for RPTX is $10.00, which is 236.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 236.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 25.50% |
| EPS Growth Forecast (5Y) | -33.69% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RPTX has an Altman Z-Score of 0.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.98 |
| Piotroski F-Score | 4 |